eli lilly and company zepbound - Search News

Eli Lilly to Offer Higher Doses of Obesity Drug Zepbound

Hosted on MSN · 4h

Eli Lilly cuts prices for Zepbound weight-loss drug again

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

The Wall Street Journal on MSN · 3h

Eli Lilly to Offer Higher Doses of Obesity Drug Zepbound at Discounted Prices

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

YAHOO!Finance · 13h

Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients

Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program.1 Lilly also reduced the price of the 2.

Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

7hon MSN

Why Eli Lilly Stock Popped Today

Eli Lilly ( LLY 2.11%) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results